secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001628280-24-036150
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Joint Corp Q2 net loss $3.6M ($0.24/sh); revenue $30.3M up 3% YoY; guidance reaffirmed
--------------------------------------------------------------------------------

- Net loss $3.6M ($0.24 loss per share) vs net loss $320K ($0.02 loss) in Q2 2023.
- Revenue $30.3M +3% YoY; system-wide sales $129.6M +8%; comp sales +2%.
- Adjusted EBITDA $2.1M vs $3.2M; includes $1.5M litigation expense and $1.4M impairment.
- Sold 7 franchise licenses (vs 21); total clinics 960; over 10 refranchise LOIs in progress.
- 2024 guidance reiterated: system-wide sales $530-545M, mid-single digit comps, 60-75 new clinics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000162828024036150/0001628280-24-036150-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000162828024036150/jynt-20240808.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-036150

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer